Joyce Teng, MD
Pediatric Dermatology · Palo Alto, CANPI 1801850854
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $82,456 of the $127,252 with a category attached, or 64.8%. It is spread thinly across 20 manufacturers, the largest accounting for just 15.2%. 2025 is the largest year on record at $43,354, 8.9 times the $4,892 reported in 2019. Among pediatric dermatology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $1167.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$19K
- Chiesi USA, Inc.$19K
- Amryt Pharma Holdings Ltd$17K
- Pfizer$15K
- Tanabe Pharma America, Inc.$9K
- Abeona Therapeutics, Inc.$7K
- plus $41K from 14 others
Across 329 payments — averaging $30,057 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$8.2M
- Amgen$934K
- Regeneron$231K
- Arcutis Biotherapeutics, Inc.$200K
- LEO Pharma AS$135K
- Pfizer$76K
- plus $86K from 7 others
What the payments were for
- Consulting fees$82,45665%
- Speaking & faculty fees$34,94227%
- Travel & lodging$6,2385%
- Food & beverage$3,5963%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 22 | $19,353 |
| Chiesi USA, Inc. | 13 | $18,732 |
| Amryt Pharma Holdings Ltd | 7 | $16,915 |
| Pfizer | 13 | $14,745 |
| Tanabe Pharma America, Inc. | 4 | $9,470 |
| Abeona Therapeutics, Inc. | 6 | $7,151 |
| Biocryst Pharmaceuticals, Inc. | 4 | $6,181 |
| Pierre Fabre Pharmaceuticals, Inc. | 8 | $5,895 |
| LEO Pharma AS | 9 | $4,672 |
| Nobelpharma America, LLC | 5 | $4,562 |
| Novartis Pharma AG | 1 | $4,000 |
| Ipsen Biopharmaceuticals, Inc | 2 | $3,885 |
| Regeneron | 1 | $3,720 |
| Incyte Corporation | 2 | $3,180 |
| LEO Pharma Inc. | 4 | $3,121 |
| Mitsubishi Tanabe Pharma Holdings America, Inc. | 1 | $1,240 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $207 |
| Regeneron Healthcare Solutions, Inc. | 1 | $134 |
| Krystal Biotech Inc | 3 | $55 |
| Bristol Myers Squibb | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$127,252 in reported general payments places this provider in the 90th percentile of 36 pediatric dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sirolimus | 31 | $30,653 |
Paid to pharmacies, not to this prescriber.
Other pediatric dermatology in Palo Alto
- Shireen GuidePalo Alto$41K
- Ilka NetravaliPalo Alto$26K
- Dawn SiegelPalo Alto$11K
- Amy GilliamPalo Alto$3K
- Ann MarquelingPalo Alto$243
- Chaw-Ning LeePalo Alto$31
- Lawrence EichenfieldSan Diego$2.8M
- Dawn EichenfieldSan Diego$252K
- Brandie MetzIrvine$41K
- Maria BuetheOrange$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.